Tuberculosis Testing Market: By Test Type, Interferon Gamma Release Analysis, Nucleic Acid Testing, Sear Microscopy, Serological Tests), By End User, and Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Tuberculosis Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Test Type (Culture Based Tests, Chest X-Ray, Mantoux Test (TST), Interferon Gamma Release Analysis (IGRA), Nucleic Acid Testing, Sear Microscopy, Serological Tests), By End User (Hospitals, Diagnostic Centres, Others), and Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Tuberculosis Testing Market size was valued at US$ 3.02 billion in 2023 and is poised to grow at a CAGR of 4.5% from 2024-2030. Tuberculosis is a bacterial infectious disease caused by Mycobacterium tuberculosis (MTB). Tuberculosis spreads through air and direct contact with the infected sputum. Tuberculosis usually affects lungs. But it can affect any other parts of the body. Tuberculosis patient generally experiences symptoms such as cough, chills, fever, fatigue, loss of weight and others. TB infecting bones can lead to joint destruction or spinal pain.

The most common diagnostic test used for TB is skin test, but it is not fully accurate. There are many tuberculosis tests are available such as bloodstream test, sputum tests, and Chest X-rays.The market is consolidated with the presence of strong market key players involving in development and marketing of the tuberculosis tests. Companies adopting the strategies such as mergers and acquisitions to strengthen their market position and expand their global reach. Furthermore, market layers also developing new testing technologies and novel products to increase their market share. 

Key Developments

  • For instance, in October 2017, Abbot Laboratories has acquired Alere Inc., to become a leading market player in point of care testing and advance its geographical reach
  • in Feb 2012, Quanterix Corporation collaborated with the Forsyth Institute and Beth Israel Deaconess Medical Center (BIDMC) to develop the fast and simple test for accurate diagnosis of tuberculosis.

summary download arrow Download Free Sample

Tuberculosis Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.5%

Largest Market

North America

Fastest Growing Market

Europe

Tuberculosis Testing Market Dynamics

Primary drivers for the global market include the rise in the disease prevalence worldwide. In addition, technological advancements in tuberculosis testing such as advent of test kits and point of care products are expected to boost the market over the forecast period. Furthermore, government initiatives for early detection and of tuberculosis coupled with an increase in adaptation of the point of care products for tuberculosis diagnosis are expected to boost the market growth over the forecast period. However, R&D cost for the development of the novel testing procedures for TB expected to hamper the market growth over the coming years.

Tuberculosis Testing Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 3.02 billion

Market CAGR

4.5%

By Test Type

  • Culture Based Tests
  • Mantoux Test (TST)
  • Interferon Gamma Release Analysis (IGRA)
  • Nucleic Acid Testing
  • Sear Microscopy
  • Serological Tests

By End User

  • Hospitals
  • Diagnostic Centres
  • Others

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The tuberculosis testing market report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The Tuberculosis Testing Market size was valued at US$ 3.02 billion in 2023 and is poised to grow at a CAGR of 4.5% from 2024-2030.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Tuberculosis Testing Market Introduction 
2.1.Global Tuberculosis Testing Market  - Taxonomy
2.2.Global Tuberculosis Testing Market  - Definitions
2.2.1.Test Type
2.2.2.End User
2.2.3.Region
3. Global Tuberculosis Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Tuberculosis Testing Market Analysis, 2019-2023 and Forecast 2024-2030
4.1.  Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Tuberculosis Testing Market  By Test Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
5.1. Culture Based Tests
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Mantoux Test (TST)
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Interferon Gamma Release Analysis (IGRA)
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Nucleic Acid Testing
5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Sear Microscopy
5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Serological Tests
5.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6. Global Tuberculosis Testing Market  By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
6.1. Hospitals
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Diagnostic Centres
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7. Global Tuberculosis Testing Market  By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. North America Tuberculosis Testing Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
8.1. Test Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Culture Based Tests
8.1.2.Mantoux Test (TST)
8.1.3.Interferon Gamma Release Analysis (IGRA)
8.1.4.Nucleic Acid Testing
8.1.5.Sear Microscopy
8.1.6.Serological Tests
8.2.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospitals
8.2.2.Diagnostic Centres
8.2.3.Others
8.3.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9. Europe Tuberculosis Testing Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
9.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Culture Based Tests
9.1.2.Mantoux Test (TST)
9.1.3.Interferon Gamma Release Analysis (IGRA)
9.1.4.Nucleic Acid Testing
9.1.5.Sear Microscopy
9.1.6.Serological Tests
9.2.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospitals
9.2.2.Diagnostic Centres
9.2.3.Others
9.3.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
10. Asia Pacific (APAC) Tuberculosis Testing Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
10.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Culture Based Tests
10.1.2.Mantoux Test (TST)
10.1.3.Interferon Gamma Release Analysis (IGRA)
10.1.4.Nucleic Acid Testing
10.1.5.Sear Microscopy
10.1.6.Serological Tests
10.2.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospitals
10.2.2.Diagnostic Centres
10.2.3.Others
10.3.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11. Middle East and Africa (MEA) Tuberculosis Testing Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
11.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Culture Based Tests
11.1.2.Mantoux Test (TST)
11.1.3.Interferon Gamma Release Analysis (IGRA)
11.1.4.Nucleic Acid Testing
11.1.5.Sear Microscopy
11.1.6.Serological Tests
11.2.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospitals
11.2.2.Diagnostic Centres
11.2.3.Others
11.3.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12. Latin America Tuberculosis Testing Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
12.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Culture Based Tests
12.1.2.Mantoux Test (TST)
12.1.3.Interferon Gamma Release Analysis (IGRA)
12.1.4.Nucleic Acid Testing
12.1.5.Sear Microscopy
12.1.6.Serological Tests
12.2.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospitals
12.2.2.Diagnostic Centres
12.2.3.Others
12.3.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Hologic, Inc.
13.2.2.Thermo Fisher Scientific, Inc. 
13.2.3.Becton, Dickinson and Company
13.2.4.Abbott Laboratories
13.2.5.bioMerieux SA
13.2.6.Hoffmann-La Roche AG
13.2.7.Cepheid
13.2.8.Sanofi S.A. 
14. Research Methodology 
15. Appendix and Abbreviations 

Key Market Players

  • Hologic, Inc.
  • Thermo Fisher Scientific, Inc. 
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • bioMerieux SA
  • Hoffmann-La Roche AG
  • Cepheid
  • Sanofi S.A. 
  • QIAGEN
  • Hain Lifescience GmbH

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market